There are 2934 resources available
EONS - Translating the YCN survey results into clinical practice: What is the way forward?
Presenter: Sara Parreira
Session: EONS 12: Collaborative session EONS YCN - ESMO YOC: Addressing the needs of young cancer professionals
Resources:
Slides
Webcast
Personalised oncogenomics: Is a precision approach necessary for every cancer or is there a therapy-driven bottleneck?
Presenter: David Huntsman
Session: Molecular tumour board: Where do we stand? What’s next?
Resources:
Slides
Webcast
Building of a comprehensive clinical and molecular genomics database for patients with treatment-refractory cancers enrolled in clinical trials
Presenter: Philippe Bedard
Session: Molecular tumour board: Where do we stand? What’s next?
Resources:
Slides
Webcast
Tissue and liquid biopsies with MTB for phase 1 trial selection: Experience in the TARGET trial
Presenter: Matthew Krebs
Session: Molecular tumour board: Where do we stand? What’s next?
Resources:
Slides
Webcast
2738 - A Randomized Phase II/III Study to Assess the Efficacy of Trametinib in Patients with Recurrent or Progressive Low-Grade Serous Ovarian or Peritoneal Cancer
Presenter: David Gershenson
Session: Proffered Paper 2 – Gynaecological cancers
Resources:
Abstract
Slides
Webcast
Proffered Paper 2 – Gynaecological cancers - Invited Discussant 992O and LBA61
Presenter: Jonathan Ledermann
Session: Proffered Paper 2 – Gynaecological cancers
Resources:
Slides
Webcast
5630 - Efficacy and safety of nivolumab (Nivo) + ipilimumab (Ipi) in patients (pts) with recurrent/metastatic (R/M) cervical cancer: Results from CheckMate 358
Presenter: Robert Naumann
Session: Proffered Paper 2 – Gynaecological cancers
Resources:
Abstract
Slides
Webcast
Proffered Paper 2 – Gynaecological cancers - Invited Discussant LBA62 and 994O
Presenter: Nicoletta Colombo
Session: Proffered Paper 2 – Gynaecological cancers
Resources:
Slides
Webcast
Setting up genomic tumour boards: What can be done and what needs to be done?
Presenter: Scott Tomlins
Session: Genomic tumour boards to deliver better prostate cancer care
Resources:
Slides
Webcast
Cancer stem cells: Are they a valid therapeutic target?
Presenter: Simone Niclou
Session: Glioblastoma treatment: Where should the future lead?
Resources:
Slides
Webcast